| 摘要 |
The inventive sustained release solid pharmaceutical composition comprises an 1-(2,3,4-trimethoxybenzyl) piperazine active substance or the pharmaceutically acceptable salt thereof combined with at least one type of polyethylene oxide, at least one type of lubricating agent and one or several pharmaceutically acceptable excipients. |
